Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Data Prediction Based on Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection

NCT05589480 is registered in ClinicalTrials.gov with Luo Cong as lead sponsor.

NCT NCT05589480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Data Prediction Based on Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection
Lead sponsor
Luo Cong
Phase
Observational
Overall status
Completed
Start date
August 1, 2022
Completion date
September 1, 2022
Enrollment
226 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer